Shanghai, China

Jingjing Ji

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Jingjing Ji in Blood Disorder Treatments

Introduction

Jingjing Ji is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of medicine, particularly in the treatment of blood disorders. With a total of seven patents to her name, her work focuses on activating pyruvate kinase, which plays a crucial role in cellular metabolism.

Latest Patents

Jingjing Ji's latest patents include innovative compounds that serve as pyruvate kinase activators for treating blood disorders. These patents describe pharmaceutical compositions and methods of use for these compounds, represented by specific formulas. The detailed descriptions highlight the potential of these activators in improving treatment outcomes for patients suffering from various blood-related conditions.

Career Highlights

Jingjing Ji is currently associated with Agios Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has garnered attention in the pharmaceutical industry, showcasing her expertise and dedication to improving healthcare solutions.

Collaborations

Some of her notable coworkers include Giovanni Cianchetta and Tao Liu, who collaborate with her on various projects within the company. Their combined efforts contribute to the innovative research being conducted at Agios Pharmaceuticals.

Conclusion

Jingjing Ji's contributions to the field of medicine through her patents and collaborations highlight her role as a leading inventor in the treatment of blood disorders. Her work continues to pave the way for advancements in pharmaceutical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…